Click graphic to enlarge
MPI Research formed a partnership with longstanding collaborators to reduce costs and accelerate decisions for your drug development programs. We strive to be the leader in early-stage development which led to this partnership which built the Translational Imaging Center. Our dedicated cyclotron, when placed in the hands of world-class synthetic chemists, generates radioisotopically labeled drug candidates suitable for molecular imaging. These labeled drug candidates can be administered to animal models on-site to assess biodistribution, target engagement, and the kinetics of distribution. This information offers insights into selecting the best drug candidate and the potential to reduce the number of drug trials and test subjects, resulting in reduced costs and accelerated decisions for Sponsors. This resource will advance the next generation of breakthrough therapeutics, while accelerating drug development with translational imaging.